Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04245345 · ClinicalTrials.gov registry record · NA
Accelerometer Sensing for Micra AV Study
A NA study, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- NA
- Development phase
- 157
- Enrollment target
NCT04245345 is a NA study that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 157 participants.
The verdict
NCT04245345, a NA study, has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
Study Summary
The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.
Interventions
- DEVICE Accelerometer Sensing for Micra AV Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2020-06-09 |
| Est. Completion | 2022-01-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04245345
The ClinicalTrials.gov registry entry for NCT04245345 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Accelerometer Sensing for Micra AV Study is the first listed.
NCT04245345 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04245345 about?
NCT04245345 is a clinical study titled "Accelerometer Sensing for Micra AV Study". The purpose of the AccelAV Study is to characterize chronic AV synchrony in subjects implanted with MicraTM AV device. This study will be conducted upon market approval of the MicraTM AV Transcatheter Pacing System.
What is the current status of trial NCT04245345?
This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2020-06-09. Estimated completion is 2022-01-10.
What interventions are being tested in trial NCT04245345?
The interventions under investigation include: Accelerometer Sensing for Micra AV Study (DEVICE).
Who is sponsoring clinical trial NCT04245345?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.